QuantLogix ← GEHC scorecard
📅 GEHC Earnings Preview
GE HealthCare Technologies Inc. Common Stock
Next report (est.)
September 12, 2026
Countdown
91 days
EPS growth YoY
-30.9%
Revenue growth YoY
+7.4%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
April 29, 2026 ±2.9% -13.2% under-priced
October 29, 2025 ±1.8% -2.5% under-priced
July 30, 2025 ±2.0% -7.8% under-priced
April 30, 2025 ±4.3% +3.3% over-priced
October 30, 2024 ±2.4% +2.3% over-priced
July 31, 2024 ±2.4% +2.4% over-priced
April 30, 2024 ±2.4% -14.3% under-priced
October 31, 2023 ±2.0% +5.4% under-priced
Across these reports, options implied an average ±2.5% move vs an actual average of 6.4% — the stock stayed inside the implied band 38% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $0.85 $5.1B $411M
Q4 FY2025 $1.29 $5.7B $602M
Q3 FY2025 $0.98 $5.1B $464M
Q2 FY2025 $1.06 $5.0B $500M
Live 5-factor engine read: Neutral · 47/100 Full scorecard →
Get alerted before every GEHC report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on GEHC before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

GE HealthCare Technologies Inc. Common Stock (GEHC) reports in 91 days, with the next report estimated for September 12, 2026. Across the last 8 reports, options priced an average ±2.5% earnings move while the stock actually moved 6.4% on average — the market has been roughly fair on GEHC's earnings risk. Fundamentals into the print: EPS down 30.9% year-over-year, revenue up 7.4%. QuantLogix's live 5-factor engine currently reads GEHC as a neutral at 47/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →